Nanographene oxide-based radioimmunoconstructs for in vivo targeting and SPECT imaging of HER2-positive tumors.

MLA

Cornelissen, Bart, et al. “Nanographene Oxide-Based Radioimmunoconstructs for in Vivo Targeting and SPECT Imaging of HER2-Positive Tumors.” Biomaterials, vol. 34, no. 4, Jan. 2013, pp. 1146–54. EBSCOhost, https://doi.org/10.1016/j.biomaterials.2012.10.054.

APA

Cornelissen, B., Able, S., Kersemans, V., Waghorn, P. A., Myhra, S., Jurkshat, K., Crossley, A., & Vallis, K. A. (2013). Nanographene oxide-based radioimmunoconstructs for in vivo targeting and SPECT imaging of HER2-positive tumors. Biomaterials, 34(4), 1146–1154. https://doi.org/10.1016/j.biomaterials.2012.10.054

Chicago

Cornelissen, Bart, Sarah Able, Veerle Kersemans, Philip A Waghorn, Sverre Myhra, Kerstin Jurkshat, Alison Crossley, and Katherine A Vallis. 2013. “Nanographene Oxide-Based Radioimmunoconstructs for in Vivo Targeting and SPECT Imaging of HER2-Positive Tumors.” Biomaterials 34 (4): 1146–54. doi:10.1016/j.biomaterials.2012.10.054.